Skip to content

Quality of Life With Esophageal Stent Trial

Prospective, Randomized Trial of the Effects on HRQoL, Cost-Utility and Reintervention Rate, of Nurse Home Visits, in Patients With SEMS Treated Malignant Disease in the Esophagus and Cardia.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01044511
Acronym
QUEST
Enrollment
80
Registered
2010-01-08
Start date
2010-01-31
Completion date
2012-03-31
Last updated
2011-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer, Gastro-esophageal Junction Cancer

Keywords

Esophageal cancer, Cardia cancer, Health Related quality of Life, SEMS, Home visits

Brief summary

The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or cardia, who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.

Detailed description

The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or gastro-esophageal junction (cardia), who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.

Interventions

BEHAVIORALHome visits

home visits by specialist nurse 2 times and 1 phonecall

BEHAVIORALstandard

hotline

Sponsors

Odense University Hospital
CollaboratorOTHER
Michael Bau Mortensen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Malignant obstruction of esophagus or cardia treated with SEMS due to non-operable disease.

Exclusion criteria

* Mentally unable to fill out questionaire

Design outcomes

Primary

MeasureTime frame
HRQoL, EORTC C-30, EOS-182 years

Countries

Denmark

Contacts

Primary ContactOle Steen Bjerring, MD
steenbjerring@gmail.com+ 45 23 84 06 96
Backup ContactMichael B Mortensen, MD, PhD
m.bau@dadlnet.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026